Correlation of specific genetic aberrations and signaling pathways with T-cell inflamed phenotype (TCIP) in head and neck cancer and as novel candidate biomarkers for checkpoint blockade therapy

MLA

Thomas F. Gajewski, et al. “Correlation of Specific Genetic Aberrations and Signaling Pathways with T-Cell Inflamed Phenotype (TCIP) in Head and Neck Cancer and as Novel Candidate Biomarkers for Checkpoint Blockade Therapy.” Journal of Clinical Oncology, vol. 33, May 2015, p. 6079. EBSCOhost, https://doi.org/10.1200/jco.2015.33.15_suppl.6079.

APA

Thomas F. Gajewski, Vassiliki Saloura, Zhixiang Zuo, Arun Khattri, Michaela K. Keck, Justin Kline, Everett E. Vokes, Mark W. Lingen, Tanguy Y. Seiwert, & Holbrook E Kohrt. (2015). Correlation of specific genetic aberrations and signaling pathways with T-cell inflamed phenotype (TCIP) in head and neck cancer and as novel candidate biomarkers for checkpoint blockade therapy. Journal of Clinical Oncology, 33, 6079. https://doi.org/10.1200/jco.2015.33.15_suppl.6079

Chicago

Thomas F. Gajewski, Vassiliki Saloura, Zhixiang Zuo, Arun Khattri, Michaela K. Keck, Justin Kline, Everett E. Vokes, Mark W. Lingen, Tanguy Y. Seiwert, and Holbrook E Kohrt. 2015. “Correlation of Specific Genetic Aberrations and Signaling Pathways with T-Cell Inflamed Phenotype (TCIP) in Head and Neck Cancer and as Novel Candidate Biomarkers for Checkpoint Blockade Therapy.” Journal of Clinical Oncology 33 (May): 6079. doi:10.1200/jco.2015.33.15_suppl.6079.